Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Q1 2025 Earnings Call Transcript May 6, 2025
Sarepta Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-3.42 EPS, expectations were $0.35.
Operator: Good afternoon, and welcome to the Sarepta Therapeutics First Quarter 2025 Financial Results Conference Call. As a reminder, today’s program is being recorded. At this time, I’ll turn the call over to Mary Jenkins, Associate Director, Investor Relations. Please go ahead.
Mary Jenkins:...
